Peramivir Market

Paramivir is a synthetic cyclopentane derivative. Functional groups which get connected to the loop include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four functional groups with different polarities act on different active site regions in the NA structure of influenza viruses. This medicine is suitable for the treatment of influenza A. It is mainly administered intravenously in the form of sodium chloride solution.
Peramivir Market aims to provide a comprehensive presentation of the global market for Peramivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peramivir. Peramivir Market contains market size and forecasts of Peramivir in global, including the following market information:
Global Peramivir Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Peramivir Market Sales, 2018-2023, 2024-2029, (Kilotons)
Global top five Peramivir companies in 2022 (%)
The global Peramivir market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solution Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals and Hunan Nucien Pharmaceutical Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peramivir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peramivir Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, by Type, 2022 (%)
Solution
Solid
Global Peramivir Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, by Application, 2022 (%)
Influenza A Treatment
Influenza B Treatment
Global Peramivir Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kilotons)
Global Peramivir Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peramivir revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peramivir revenues share in global market, 2022 (%)
Key companies Peramivir sales in global market, 2018-2023 (Estimated), (Kilotons)
Key companies Peramivir sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peramivir, market overview.
Chapter 2: Global Peramivir market size in revenue and volume.
Chapter 3: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peramivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peramivir capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.